Mori Tetsuya

FacultyBiomedical Imaging Research Center
Teacher OrganizationBiomedical Imaging Research Center
Education and
 Research Organization
Biomedical Imaging Research Center
PositionAssistant Professor
Last Updated: 19/05/22 16:44

Researcher Profile & Settings

Name

    Mori Tetsuya

Affiliation

  •  Biomedical Imaging Research Center Assistant Professor

Education

  • Apr. 2003Mar. 2007Fukui Medical School Graduate School, Division of Medicine 形態学
  • Apr. 1996Mar. 1998Osaka University of Pharmaceutical Sciences 放射薬品学専攻
  • 1996Osaka University of Pharmaceutical Sciences Pharmaceutical Department

Academic & Professional Experience

  • Apr. 1998Mar. 2002Hyogo Institute for Aging Brain and Cognitive Disorders Researcher

Association Memberships

    Society of Nuclear Medicine member,Japanese Society of Molecular Imaging member,

Research Activities

Published Papers

  • Predictive value of early stage uptake of 3'-deoxy-3'-18F-fluorothymidine in cancer cells treated with charged particle irradiation.
    C.Lin, K.Kume, T.Mori, ME.Martinez , H.Okazawa, Y.Kiyono
    J Nucl Med 56(6) 945-950 Jun.  2015 Refereed
  • Assessing Tumor Hypoxia in Head and Neck Cancer by PET With Cu-62-Diacetyl-Bis(N-4-Methylthiosemicarbazone)
    Sato, Yoshitaka;Tsujikawa, Tetsuya;Oh, Myungmi;Mori, Tetsuya;Kiyono, Yasushi;Fujieda, Shigeharu;Kimura, Hirohiko;Okazawa, Hidehiko
    CLINICAL NUCLEAR MEDICINE 39(12) 1027-1032 2014
  • Evaluation of target sites for nano-irradiation therapy with Auger electron
    Kiyono, Yasushi;Mori, Tetsuya;Asai, Tatsuya;Yoshii, Yukie;Okazawa, Hidehiko
    JOURNAL OF NUCLEAR MEDICINE 55 2014
  • Development of a low cost flexible module system for F-18 labeled PET tracer production
    Mori, Tetsuya;Takaki, Kenji;Fujibayashi, Yasuhisa;Okazawa, Hidehiko;Kiyono, Yasushi
    JOURNAL OF NUCLEAR MEDICINE 55 2014
  • Volume-based hypoxic parameters of 62Cu-ATSM PET as prognostic indicators in head and neck cancer
    Tsujikawa, Tetsuya;Asahi, Satoko;Oh, Myungmi;Sato, Yoshitaka;Tsuchida, Tatsuro;Makino, Akira;Mori, Tetsuya;Kiyono, Yasushi;Fujieda, Shigeharu;Okazawa, Hidehiko
    JOURNAL OF NUCLEAR MEDICINE 55 2014
  • Evaluation of cerebral oxidative stress in amyotrophic lateral sclerosis using Cu-62-ATSM PET
    Okazawa, Hidehiko;Ikawa, Masamichi;Tsujikawa, Tetsuya;Matsunaga, Akiko;Mori, Tetsuya;Kiyono, Yasushi;Yoneda, Makoto
    JOURNAL OF NUCLEAR MEDICINE 55 2014
  • Assessing Tumor Hypoxia in Head and Neck Cancer by PET With 62Cu-Diacetyl-Bis(N4-Methylthiosemicarbazone)
    Y.Sato, T.Tsujikawa, M.Oh, T.Mori, Y.Kiyono, S.Fujieda, H.Kimura, H.Okazawa
    Clin Nucl Med 39(12) 1027-1032 Dec.  2014 Refereed
  • Development and evaluation of a radio bromine-labeled sigma ligand for tumor imaging
    Kazuma Ogawa, Hiroya Kanbara, Yasushi Kiyono, Yoji Kitamura, Tatsuto Kiwada, Takashi Kozaka, Masanori Kitamura, Tetsuya Mori, Kazuhiro Shiba, Akira Odani
     40(4) 445-450 May  2013 Refereed
  • 18F-FES and 18F-FDG PET for Differential Diagnosis and Quantitative Evaluation of Mesenchymal Uterine Tumors: Correlation with Immunohistochemical Analysis
    Z.Zhao, Y.Yoshida, T.Kurokawa, Y.Kiyono, T.Mori, H.Okazawa
     54(4) 499-506 Apr.  2013 Refereed
  • Positron Emission Tomography Radiopharmaceuticals for Sex Steroid Hormone Receptor Imaging
    Y.Kiyono, T.Mori, H.Okazawa
     19(20) 3266-3270 Jun.  2012 Not refereed
  • Oestrogen-related tumour phenotype: PET characterisation with 18F-FDG and 18F-FES
    T.Tsujikawa, Y.Yoshida, H.Maeda, T.Tsuchida, T.Mori, Y.Kiyono, H.Kimura, H.Okazawa
     85(1015) 1020-1024 Jun.  2012 Refereed
  • Different distribution of 62Cu ATSM and 18F-FDG in head-and-neck cancers
    A.Kositwattanarerk, M.Oh, T.Kudo, Y.Kiyono, T.Mori, Y.Kimura, R.Maruyama, Y.Fujibayashi, S.Fujieda, H.Okazawa
     37(3) 252-257 Mar.  2012 Refereed
  • Appropriate parameters of ordered-subset expectation maximization algorithm on measurement of myocardial blood flow and oxygen consumption with 11C-acetate PET
    M.Kobayashi, T.Mori, Y.Kiyono, T.Tsujikawa, R.Maruyama, Y.Higaki, N.Shikano, R.Nishii, K.Kawai, T.Kudo, H.Okazawa
     33(2) 130-138 Feb.  2012 Refereed
  • Radiolabeled Cu-ATSM as a novel indicator of over-reduced intracellular state due to mitochondrial dysfunction: studies with mitochondrial DNA-less rho0 cells and cybrids carrying MELAS DNA mutation
    Y.Yoshii, M.Yoneda, M.Ikawa, T.Furukawa, Y.Kiyono, T.Mori, H.Yoshii, N.Oyama, H.Okazawa, T.Saga, Y.Fujibayashi
     39(2) 117-185 Feb.  2012 Refereed
  • Cerebral oxygen metabolism of rats using injectable 15O-oxygen with a steady-state method
    M.Kobayashi, T.Mori, Y.Kiyono, V.N.Tiwari, R.Maruyama, K.Kawai, H.Okazawa
     32(1) 33-40 Jan.  2012 Refereed
  • New radiosynthesis of 2-deoxy-2-[18F]fluoroacetamido-D-glucopyranose and its evaluation as a bacterial infections imaging agent
    M.E.Martinez, Y.Kiyono, S.Noriki, K.Inai, K.S.Mandap, M.Kobayashi, T.Mori, Y.Tokunaga, V.N.Tiwari, H.Okazawa, Y.Fujibayashi, T.Ido
     38(6) 807-817 Aug.  2011 Refereed
  • Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease
    M.Isozaki, Y.Kiyono, Y.Arai, T.Kudo, T.Mori, R.Maruyama, K.Kikuta, H.Okazawa
     38(6) 1075-1082 Jun.  2011 Refereed
  • Development of an H215O steady-state method combining a bolus and slow increasing injection with a multi-programming syringe pump
    M.Kobayashi, Y.Kiyono, R.Maruyama, T.Mori, K.Kawai, H.Okazawa
     31(2) 527-534 Feb.  2011 Refereed
  • Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma
    Y.Yoshii, T.Furukawa, Y.Kiyono, R.Watanabe, A.Waki, T.Mori, H.Yoshii, M.Oh, T.Asai, H.Okazawa, M.J.Welch, Y.Fujibayashi
    Nucl Med Biol 37(4) 395-404 May  2010 Refereed
  • Automatic labeling method for injectable 15O-oxygen using hemoglobin-containing liposome vesicles and its application for measurement of brain oxygen consumption by PET
    V.N.Tiwari, Y.Kiyono, M.Kobayashi, T.Mori, T.Kudo, H.Okazawa, Y.Fujibayashi
     37(1) 77-83 Jan.  2010 Refereed
  • Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism
    Y.Yoshii, T.Furukawa, H.Yoshii, T.Mori, Y.Kiyono, A.Waki, M.Kobayashi, T.Tsujikawa, T.Kudo, H.Okazawa, Y.Fujibayashi
     100(5) 821-827 May  2009 Refereed
  • Development of microwave-based automated nucleophilic [18F]fluorination system and its application to the production of [18F]flumazenil
    K.S.Mandap, T.Ido, Y.Kiyono, M.Kobayashi, T.G.Lohith, T.Mori, S.Kasamatsu, T.Kudo, H.Okazawa, Y.Fujibayashi
     36(4) 403-409 May  2009 Refereed
  • Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model
    M.Oh, T.Tanaka, M.Kobayashi, T.Furukawa, T.Mori, T.Kudo, S.Fujieda, Y.Fujibayashi
    Nucl Med Boil 36(4) 419-426 May  2009 Refereed
  • Preparation and evaluation of ethyl [18F]fluoroacetate as a pro-radiotracer of [18F]luoroacetate for the measurement of glial metabolism by PET
    T.Mori, Li-Quan Sun, M.Kobayashi, Y.Kiyono, H.Okazawa, T.Furukawa, H.Kawashima, M.J. Welch, Y.Fujibayashi
     36(2) 155-162 Feb.  2009 Refereed
  • Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET
    Y.Yoshii, A.Waki, T.Furukawa, Y.Kiyono, T.Mori, H.Yoshii, T.Kudo, H.Okazawa, MJ Welch, Y.Fujibayashi
    Nuclear Medicine and Biology 36(7) 771-777 Jan.  2009 Refereed
  • Basic evaluation of FES-hERL PET tracer-reporter gene system for in vivo monitoring of adenoviral-mediated gene therapy
    T.G.Lohith, T.Furukawa, T.Mori, M.Kobayashi, Y.Fujibayashi
     10(5) 245-252 Sep.  2008 Refereed
  • Uterine tumors: Pathophysiologic imaging with 16α-[18F]fluoro-17β-estradiol and FDG-PET ? Initial experience
    T.Tsujikawa, Y.Yoshida, T.Mori, T.Kurokawa, Y.Fujibayashi, F.Kotsuji, H.Okazawa
    Radiology 248(2) 599-605 Aug.  2008 Refereed
  • Non-standard radionuclide production for PET in Japan
    Y.Fujibayashi, K.Suzuki, T.Furukawa, T.Mori, S.Kasamatsu
    Q J Nucl Mol Imaging 52(2) 140-144 Jun.  2008 Not refereed
  • Distinctive FDG and FES accumulation pattern of two tamoxifen treated patients with endometrial hyperplasia
    T.Tsujikawa, H.Okazawa, Y.Yoshida, T.Mori, M.Kobayashi, T.Tsuchida, Y.Fujibayashi
    Ann Nucl Med 22(1) 73-77 Jan.  2008 Refereed
  • Ovarian theca cells in follicular function
    K.Tajima, M,Orisaka, T.Mori, F,Kotsuji
    RBM Online 15(5) 591-609 Nov.  2007 Refereed
  • In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET - influence of menstrual cycle and endogenous estrogen level
    T.Tsuchida, H.Okazawa, T.Mori, M. Kobayashi, Y.Yoshida, Y.Fujibayashi, H.Itoh
    Nucl Med Biol 34(2) 205-210 Feb.  2007 Refereed
  • Automatic synthesis of 16 alpha-[18F]fluoro-17beta-estradiol using a cassette-type [18F]fluorodeoxyglucose synthesizer
    T.Mori, S.Kasamatsu, C.Mosdzianowski, M.J.Welch, Y.Yonekura, Y.Fujibayashi
     33(2) 281-286 Feb.  2006 Refereed
  • Effects of 5-HT1B/1D receptor agonist rizatriptan on cerebral blood flow and blood volume in normal circulation
    H.Okazawa, T.Tsuchida, M.Pagani, T.Mori, M.Kobayashi, F.Tanaka, Y.Yonekura
    J Cereb Blood Flow Metab 26(1) 92-98 Jan.  2006 Refereed
  • New approach to fully automated synthesis of sodium [18F]fluoroacetate - a simple and fast method using a commercial synthesizer
    L.Q.Sun, T.Mori, C.S.Dence, D.E.Ponde, M.J.Welch, T.Furukawa, Y.Yonekura, Y.Fujibayashi
     33(1) 153-158 Jan.  2006 Refereed
  • Potential of the FES-hERL PET reporter gene system - basic evaluation for gene therapy monitoring
    T.Furukawa, T.G.Lohith, S.Takamatsu, T.Mori, T.Tanaka, Y.Fujibayashi
     33(1) 145-151 Jan.  2006 Refereed
  • Noninvasive imaging of transplanted living functional cells transfected with a reporter estrogen receptor gene
    S.Takamatsu, T.Furukawa, T.Mori, Y.Yonekura, Y.Fujibayashi
     32(8) 821-829 Nov.  2005 Refereed
  • Comparison of image quality with 62Cu and 64Cu-labeled radiotracers in positron emission tomography whole-body phantom imaging.
    M.Kobayashi, T.Mori, T.Tsujikawa, K.Ogai, J.Sugama, Y.Kiyono, K.Kawai, H.Okazawa
    Hell J Nucl Med 18(2) 103-107 May  2015 Refereed
  • Assessment of the Tumor Redox Status in Head and Neck Cancer by 62Cu-ATSM PET.
    Tsujikawa T, Asahi S, Oh M, Sato Y, Narita N, Makino A, Mori T, Kiyono Y, ;Tsuchida T, Kimura H, Fujieda S, Okazawa H
    PLoS ONE 11(5) e0155635 May  2016 Refereed
    PURPOSE:Tumor redox is an important factor for cancer progression, resistance to treatments, and a poor prognosis. The aim of the present study was to define tumor redox (over-reduction) using 62Cu-diacetyl-bis(N4-methylthiosemicarbazone) (62Cu-ATSM) PET and compare its prognostic potential in head and neck cancer (HNC) with that of 2-deoxy-2-[18F]fluoro-D-glucose (18F-FDG).;METHODS:Thirty HNC patients (stage II-IV) underwent pretreatment 62Cu-ATSM and 18F-FDG PET scans. Maximum standardized uptake values (SUVATSM and SUVFDG) and tumor-to-muscle activity concentration ratios (TMRATSM and TMRFDG) were measured. Reductive-tumor-volume (RTV) was then determined at four thresholds (40%, 50%, 60%, and 70% SUVATSM), and total-lesion-reduction (TLR) was calculated as the product of the mean SUV and RTV for 62Cu-ATSM. In 18F-FDG, metabolic-tumor-volume (MTV) and total-lesion-glycolysis (TLG) were obtained at a threshold of 40%. A ROC analysis was performed to determine % thresholds for RTV and TLR showing the best predictive performance, and these were then used to determine the optimal cut-off values to stratify patients for each parameter. Progression-free-survival (PFS) and cause-specific-survival (CSS) were evaluated by the Kaplan-Meier method.;RESULTS:The means ± standard deviations of PFS and CSS periods were 16.4±13.4 and 19.2±12.4 months, respectively. A ROC analysis determined that the 70% SUVATSM threshold for RTV and TLR was the best for predicting disease progression and cancer death. Optimal cut-offs for each index were SUVATSM = 3.6, SUVFDG = 7.9, TMRATSM = 3.2, TMRFDG = 5.6, RTV = 2.9, MTV = 8.1, TLR = 14.0, and TLG = 36.5. When the cut-offs for TMRATSM and TLR were set as described above in 62Cu-ATSM PET, patients with higher TMRATSM (p = 0.03) and greater TLR (p = 0.02) showed significantly worse PFS, while patients with greater TLR had significantly worse CSS (p = 0.02). Only MTV in 18F-FDG PET predicted differences in PSF and CSS (p = 0.03 and p = 0.03, respectively).;CONCLUSION:Tumor redox parameters measured by 62Cu-ATSM PET may be determinants of HNC patient outcomes and help define optimal patient-specific treatments.
  • Increased oxidative stress is related to disease severity in the ALS motor cortex: A PET study
    M.Ikawa,H.Okazawa,T.Tsujikawa,A.Matsunaga,O.Yamamura,T.Mori,T.Hamano,Y,Kiyono,Y.Nakamoto,M.Yoneda
    Neurology 84(20) 2033-2039 May  2015 Refereed
  • Estimation of arterial input by a noninvasive image derived method in brain H215O PET study confirmation of arterial location using MR angiography
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H
    Phys Med Biol 62(11) 4514-4524 Jun.  2017 Refereed
  • 18F-FDG/18F-FES standardized uptake value ratio determined using PET predicts prognosis in uterine sarcoma
    Yamamoto M, Tsujikawa T, Yamada S, Kurokawa T, Shinagawa A, Chino Y, Mori T, Kiyono Y, Okazawa H, Yoshida Y
    Oncotarget 8(14) 22581-22589 Apr.  2017 Refereed
    :We investigated whether 16α-[18F]-fluoro-17β-estradiol (18F-FES) and 18F-fluoro-deoxyglucose (FDG) uptake measured using positron emission tomography (PET) predicted prognosis in 18 patients with different histological subtypes of uterine sarcoma. Standardized uptake values (SUVs) and 18F-FDG/18F-FES SUV ratios were determined, and their correlations with progression-free (PFS) and overall survival (OS) were examined. Ten patients died from local recurrence or metastasis, and one more experienced recurrence, during the at least 36-month follow-up period. Patients with higher 18F-FDG SUVs (> 5.5) had worse OS (p = 0.007) and tended toward worse PFS (p = 0.11), while patients with lower 18F-FES SUVs (竕、 1.5) had worse PFS (p = 0.03) and tended toward worse OS (p = 0.19). Patients with 18F-FDG/18F-FES ratios > 2.6 had worse PFS (p = 0.009) and OS (p = 0.005). The 5-year PFS and OS rates were 75% and 88% for patients with lower ratios, but were only 10% and 20% for those with higher ratios. These results suggest that pretreatment tumor 18F-FDG/18F-FES ratio is useful for predicting the prognosis of uterine sarcoma patients.
  • Pixel-by-pixel precise delay correction for measurement of cerebral hemodynamic parameters in H2(15)O PET study
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H
    Ann Nucl Med 31(4) 283-294 May  2017 Refereed
    OBJECTIVE:A new method of delay time estimation was proposed to measure precise cerebral blood flow (CBF) and arterial-to-capillary blood volume (V 0) using (15)O-water PET.;METHODS:Nineteen patients with unilateral arterial stenoocclusive lesions were studied to evaluate hemodynamic status before treatment. The delay time of each pixel was calculated using least squares fitting with an arterial blood input curve adjusted to the internal carotid artery counts at the skull base. Pixel-by-pixel delay estimation provided a delay map image that could be used for precise calculation of CBF and V 0 using a one-tissue compartment model, and the values from this method were compared with those from the slice-by-slice correction method.;RESULTS:The affected side showed a longer delay time than the contralateral cerebral hemisphere. Although the mean cortical CBF values were not different between the two methods, the slice-by-slice delay correction overestimatedツ?CBF in the hypo perfused area. The scatter plot of V 0 pixel values showed significant difference between the two correction methods where the slice-by-slice delay correction significantly overestimated V 0 in the whole brain (P窶?<窶?0.05).;CONCLUSION:Pixel-by-pixel delay correction provides delay images as well as better estimation of CBF and V 0, thus offering useful and beneficial information for the treatment of cerebrovascular disease.
  • Noninvasive method for measurement of cerebral blood flow using O-15 water PET/MRI with ASL correlation
    Okazawa H, Higashino Y, Tsujikawa T, Arishima H, Mori T, Kiyono Y, Kimura H, Kikuta K
    Eur J Radiol 105 102-109 Jun.  2018 Refereed
  • No significant difference found in PET/MRI CBF values reconstructed with CT-atlas-based and ZTE MR attenuation correction
    Okazawa H, Tsujikawa T, Higashino Y, Kikuta K, Mori T, Makino A, Kiyono Y
    Eur J Nucl Med Mol Img Re 9(1) 26 Mar.  2019 Refereed
  • 18F-FLT PET/MRI for bone marrow failure syndrome-initial experience
    Tsujikawa T, Tasaki T, Hosono N, Mori T, Makino A, Kiyono Y, Zanotti-Fregonara P, Yamauchi T, Okazawa H
    Eur J Nucl Med Mol Img Re 9(1) 26 Feb.  2019 Refereed

Conference Activities & Talks

  • Increased cerebral oxidative stress in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study
    K.Miyazaki, M.Ikawa, T.Tsujikawa, T.Mori, T.Hamano, Y.Nakamoto, Y.Kiyono, H.Okazawa, M.Yoneda
    The 11th Conference of Asian Society for Mitochondrial Research and Medicine Nov.  2014
  • Hypoxic volume measurement using Cu-ATSM PET may be a predictive index for prognosis of advanced head-and-neck cancers: Comparison with FDG-PET.
    H.Okazawa, T.Tsujikawa, M.Oh, Y.Sato, T.Mori, S.Fujieda, Y.Kiyono
     Sep.  2014
  • Comparison of target sites for exploring an effective nano-irradiation therapy using Auger electron.
    Y.Kiyono, T.Mori, T.Asai, Y.Yoshii, H.Okazawa
     Sep.  2014
  • Predictive value of early stage uptake of 18F-FLT in colorectal cancer treated with charged particle radiotherapies
    C.Lin, K.Kume, T.Mori, M.E.Martinez, H.Okazawa, Y.Kiyono
     Sep.  2014
  • Evaluation of cerebral oxidative stress in amyotrophic lateral sclerosis using 62Cu-ATSM PET.
    H.Okazawa, M.Ikawa, T.Tsujikawa, A.Matsunaga, T.Mori, Y.Kiyono, M.Yoneda
     Jun.  2014
  • Volume-based hypoxic parameters of 62Cu-ATSM PET as prognostic indicators in head and neck cancer
    T.Tsujikawa, S.Asahi, M. Oh, Y. Sato, T.Tsuchida, A. Makino, T.Mori, Y.Kiyono, S.Fujieda, H.Okazawa
    The 61st Annual Meeting of The Society of Nuclear Medicine Jun.  2014
  • Evaluation of target sites for nano-irradiation therapy with Auger electron.
    Y.Kiyono, T.Mori, T.Asai, Y.Yoshii, H.Okazawa
     Jun.  2014
  • Development of a low cost flexible module system for F-18 labeled PET tracer production
    T.Mori, K.Takaki, Y.Fujibayashi, H.Okazawa, Y.Kiyono
     Jun.  2014
  • In vitro and in vivo evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring early therapeutic responses to charged particle radiotherapies
    C.Lin, K.Kume, T.Mori, M.E.Martinez, T.Takata, H.Okazawa, Y.Kiyono
     May  2014
  • Increased cerebral oxidative stress in amyotrophic lateral sclerosis: a 62Cu-ATSM PET study
    M.Ikawa, H.Okazawa, T.Tsujikawa, T.Muramatsu, T.Kishitani, T.Kamisawa, A.Matsunaga, O.Yamamura, T.Mori, T.Hamano, Y.Kiyono, Y.Nakamoto, M.Yoneda
    2014 AAN May  2014
  • Evaluation of radiobrominated (2S,αS)-2-(α-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain norepinephrine transporter
    Y.Kiyono, T.Mori, Miguel Martinez, T.Asai, H.Okazawa
     Mar.  2014
  • Evaluation of target sites for nano-irradiation therapy with Auger electron.
    Y.Kiyono, T.Mori, T.Asai, Y.Yoshii, H.Okazawa
     Mar.  2014
  • PET Imaging of Estrogen Receptors in Metastatic Breast Cancer Patients
    H.Maeda, M.Nakazawa, T.Tsuchida, Y.Imamura, T.Mori, T.Tsujikawa, A.Yamaguchi, H.Okazawa
     Mar.  2014
  • Regional changes in cerebral oxidative stress of neurodegenerative disease evaluated by 62Cu-ATSM PET
    M.Yoneda, M. Ikawa, T.Tsujikawa, A.Matsunaga, T.Mori, Y.Kiyono, H.Okazawa
     Mar.  2014
  • In vitro and in vivo evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring early therapeutic responses to charged particle radiotherapies.
    C.Lin, K.Kume, T.Mori, M.E.Martinez, T.Takata, H.Okazawa, Y.Kiyono
     Mar.  2014
  • Regional changes in cerebral oxidative stress evaluated by 62Cu-ATSM PET in patients with amyotrophic lateral sclerosis.
    M.Yoneda, M. Ikawa, T.Tsujikawa, A.Matsunaga, T.Mori, Y.Kiyono, H.Okazawa
     Mar.  2014
  • In vitro and in vivo evaluation of 3'-deoxy-3'-18F-fluorothymidine for monitoring early therapeutic responses to charged particle radiotherapies
    C.Lin, K.Kume, T.Mori, M.E. Martinez, T.Takata, H.Okazawa, Y.Kiyono
     Mar.  2014
  • Evaluation of new precursors for radiosynthesis of 2-deoxy-2-[18F]fluoroacetamido-D-glucopyranose
    M.E.Martinez, Y.Tokunaga, T.Mori, S.Noriki, K.Inai, T.Ido, H.Okazawa, Y.Kiyono
     Mar.  2014
  • Fully automated production of [18F]fluoroacetate on a compact FDG synthesizer
    T.Mori, R.Arai, D.Blampain, T.Kosuga, T.Asai, Y.Fujibayashi, H.Okazawa, Y.Kiyono
    International Workshop on Molecular Functional Imaging for Brain and Gynecologic Oncology Mar.  2014
  • Development of a flexible synthesis module system for F-18 labeled PET tracer
    T.Mori, T.Takaki, Y.Fujibayashi, T.Asai, H.Okazawa, Y.Kiyono
     Mar.  2014
  • Which target site is effective for nano-irradiation therapy using Auger electron?
    Y.Kiyono, T.Mori, T.Asai, Y.Yoshii, H.Okazawa
     Jan.  2014
  • HPLC and HPLC-ESI-MS/MS methods for the determination of 2-acetamido-2-deoxy-D-glucopyranose analogues
    M.E.Martinez, Y.Tokunaga, T.Mori, A.Makino, S.Noriki, K.Inai, H.Okazawa, Y.Kiyono
     Jan.  2014
  • PET imaging of cerebral oxidative stress in neurodegenerative disorders
    M.Yoneda, M.Ikawa, T.Tsujikawa, T.Mori, T.Hamano, Y.Nakamoto, Y.Kiyono, H.Okazawa
    5th World Congress on Targeting Mitochondria Jan.  2014
  • Cu-ATSM uptake may predict prognosis after treatment in advanced head-and-neck cancers: Evaluation of resistant hypoxic tissue with tumor-to-muscle ratio
    Y.Sato, M.Oh, Y.Kimura, Y.Kiyono, T.Mori, S.Fujieda, H.Okazawa
     Dec.  2013
  • Tumor-to-muscle ratio of Cu-ATSM uptake may reflect outcome of treatment in head-and-neck cancers: Predictability of resistant hypoxic tissue.
    Y.Sato, M.Oh, Y.Kimura, Y.Kiyono, T.Mori, S.Fujieda, H.Okazawa
     Jun.  2013
  • Imaging of changes in norepinephrine transporter in depression model rats with a radiobrominated (2S, αS)-2-(α-(2-bromophenoxy)benzyl)morpholine.
    Y.Kiyono, M.Kashiwahara, N.Omata, T.Mizuno, T.Mori, T.Asai, H.Okazawa
    The 60th Annual Meeting of The Society of Nuclear Medicine Jun.  2013
  • Predictability of later developed relapse in endometrial carcinoma in young women with functional imaging parameters of FES/FDG SUV ratio after hormone treatment.
    Y.Yoshida, T.Kurokawa, H.Tsuyoshi, A.Shinagawa, Y.Kiyono, T.Mori, H.Okazawa
     Jun.  2013
  • Predictability of later developed relapse in endometrial carcinoma in young women with functional imaging parameters of FES/FDG SUV ratio after hormone treatment.
    Y.Yoshida, H.Okazawa, A.Shinagawa, Y.Kiyono, T.Mori, T.Kurokawa
    2013 ASCO Annual Meeting Jun.  2013
  • Fully automated production of [18F]fluoroacetate on IBA Synthera platform
    T.Mori, R.Arai, D.Blampain, C.Gameiro-Paris, T.Kosuga, T.Asai, Y.Fujibayashi, H.Okazawa, Y.Kiyono
     May  2013
  • Predictability of treatment effects with Cu-ATSM PET in head-and-neck cancers: Comparison with FDG-PET.
    H.Okazawa, Y.Kimura, M.Oh, Y.Kiyono, T.Mori, S.Fujieda
     Sep.  2012
  • Feasibility of 62Cu-ATSM PET and its predictability of treatment effects in head-and-neck cancers: Comparison of 62Cu-ATSM and 18F-FDG PET.
    佐藤 義高, 呉 明美, 木村 有一, 清野 泰, 森 哲也, 藤枝 重治, 岡沢 秀彦
    Japan Advanced Molecular Imaging Program Symposium 2012 Aug.  2012
  • Evaluation of radiobromine-labeled (2S,αS)-2-(α-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain norepinephrine transporter.Evaluation of radiobromine-labeled (2S,αS)-2-(α-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain norepinephrine transporter.
    Y.Kiyono, T.Mori, T.Asai, Y.Fujibayashi, H.Okazawa
     Jun.  2012
  • Evaluation of 5-[77Br]bromo-4’-thio-2’-deoxyuridine as a radiopharmaceutical for DNA targeted nanoirradiation therapy.
    Y.Kiyono, R.Ikeda, T.Mori, Y.Yoshii, Y.Fujibayashi, H.Okazawa
     Jun.  2012
  • Predictability of 62Cu-ATSM uptake to evaluate resistant hypoxic tissue and effects of treatment in head-and-neck cancers
    H.Okazawa, Y.Kimura, Y.Kiyono, T.Mori, S.Fujieda
     Jun.  2012
  • Developement of an automatic Copper-62 ATSM preparation module in asceptic condition.
    T.Mori, K.Takaki, Y.Kiyono, Y.Fujibayashi, H.Okazawa
     Jun.  2012
  • Relationship between effects of treatment and Cu-ATSM uptake in head-and-neck cancers: Predictability of resistant hypoxic tissue in cancers.
    H.Okazawa, Y.Kimura, M.Oh, Y.Kiyono, T.Mori, S.Fujieda
     Jan.  2012
  • Evaluation of 5-[77Br]bromo-4’-thio-2’-deoxyuridine as a radiopharmaceutical for DNA targeted internal radiation therapy.
    Y.Kiyono, R.Ikeda, T.Mori, Y.Yoshii, T.Asai, Y.Fujibayashi, H.Okazawa
     Jan.  2012
  • Assessment of 16α-[18F] Fluoro-17β-Estradiol as a New PET Tracer for Evaluating ER Expression of Prostate Cancer Following Androgen Ablation Therapy.
    Y.Hasegawa, N.Oyama, N.Takahara, Y.Miwa, H.Akino, T.Mori, Y.Kiyono, O.Yokoyama
     Jan.  2012
  • Radiolabeled Cu-ATSM as a novel indicator of over-reduced states in mitochondrial disorders: studies with mtDNA-less rho0 cells and the cybrids carrying MELAS mtDNA mutation
    Y.Yoshii, M.Yoneda, M.Ikawa, T.Furukawa, Y.Kiyono, T.Mori, H.Yoshii, N.Oyama, H.Okazawa, T. Saga, Y.Fujibayashi
     Sep.  2011
  • Evaluation of radiobrominated (2S,aS)-2-(a-(2-bromophenoxy)benzyl)morpholine for imaging brain norepinephrine transporter
    Y.Kiyono, T.Takuda, K.Sano, R.Ikeda, T.Mori, M.Martinez, T.Asai, Y.Fujibayashi, H.Okazawa
     Aug.  2011
  • Automated synthesis of [18F]fluoroacetate using a compact FDG synthesizer
    T.Mori, R.Arai, B.Lambert, C.Gameiro-Paris, T.Kosuga, T.Asai, Y.Fujibayashi, H.Okazawa, Y.Kiyono
     Aug.  2011
  • Development of a flexible automatic synthesis module system for PET probe preparation
    Tetsuya Mori, Ryo Watanabe, Yasushi Kiyono, Yukie Yoshii, Hidehiko Okazawa, Yasuhisa Fujibayashi
    Society of Nuclear Medicine, the 58th Annual Meeting Jun.  2011
  • Additional diagnostic value of [F-18]-fluoroestradiol PET in patients with uterine smooth muscle tumors.
    Y.Yoshida, Y.Kiyono, T.Kurokawa, T.Tsujikawa, T.Mori, F.Kotsuji, H.Okazawa
     Jun.  2011
  • A novel application of radiolabeled Cu-ATSM as an indicator of intracellular over-reduced states in disorders with mitochondrial dysfunction: Studies with cybrids carrying mitochondrial DNA mutation from MELAS patients.
    Y.Yoshii, M.Yoneda, M.Ikawa, T.Furukawa, Y.Kiyono, T.Mori, H.Yoshii, N.Oyama, H.Okazawa, Y.Fujibayashi
     Jun.  2011
  • In ultra-short ECG gated acquisition of C-11 acetate PET reliable for simultaneous MBF, oxidative metabolism and myocardial function assessment?
    T.Kudo, K.Sarasawa, A.Nakano, T.Mori, Y.Kiyono, H.Okazawa
     Jun.  2011
  • In vivo evaluation of radiobromine-labeled 5-bromo-4-thio-2'-deoxyuridine as an imaging agent for tumor proliferation.
    Y.Kiyono, S.Sano, T.Mori, J.Toyohara, M.E.Martinez, T.Asai, H.Okazawa, Y.Fujibayashi
     Jun.  2011
  • Radiolabeled Cu-ATSM as a novel indicator of over-reduced states due to mitochondrial dysfunction: studies with mtDNA-less rho0 cells and the cybrids carrying MELAS mtDNA mutation
    M.Yoneda, Y.Yoshii, M.Ikawa, T.Takeda, T.Furukawa, Y.Kiyono, T.Mori, H.Yoshii, N.Oyama, H.Okazawa, Y.Fujibayashi
     Jun.  2011
  • Development and evaluation of a radiobromine labeled sigma ligand for tumor imaging
    K. Ogawa, H. Kanbara, K. Shiba, K. Kiyono, T. Mori, Y. Kitamura, T. Kozaka, T. Kiwada, A. Odani
     Jan.  2011
  • Evaluation of radiobrominated (2S,aS)-2-(a-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain norepinephrine transporter
    Y.Kiyono, T.Kakuda, R.Ikeda, K.Sano, T.Mori, M.Martinez, T.Asai, Y.Fujibayashi, H.Okazawa
     Jan.  2011
  • Predictive value of tracer accumulation to evaluate effects of cancer treatment studied using 62Cu-ATSM and 18F-FDG PET in head-and-neck cancers.
    H.Okazawa, A.Kositwattanarerk, Y.Kimura, Y.Kiyono, T.Mori, S.Fujieda
     Jan.  2011
  • Development of automatic synthesis of 16β-[18F]fluoro-5α-dihydrotestosterone using a plastic cassette-type FDG synthesizer
    T.Mori, C.S.Dence, M.J.Welch, Y.Fujibayashi, H.Okazawa, Y.Kiyono
     Jan.  2011
  • Design and application of a flexible synthesis module system for PET probes
    T.Mori, R. Watanabe, Y.Yoshii, Y.Kiyono, Y.Fujibayashi
     Dec.  2010
  • Investigation on accumulation and therapeutic effect of64 Cu-ATSM in mouse colon carcinoma model: the relation to CD133+ highly tumorigenic cells
    Y.Yoshii, T.Furukawa, Y.Kiyono, R.Watanabe, T.Mori, H.Yoshii, H.Okazawa, M.J.Welch, Y.Fujibayashi
    2010 International Chemical Congress of Pacific Basin Societies Dec.  2010
  • Cu-ATSM is a novel indicator of intercellular over-reduced states in mitochondrial dysfunction: fundamental evaluation using mitochondrial DNA-less(ρ0)cells and cybrids carrying causal mitochondrial DNA mutation of MELAS syndrome
    Y.Kuroda, Y.Yoshii, M.Yoneda, M.Ikawa, Y.Kiyono, T.Mori, H.Yoshii, T.Furukawa, T.Asai, H.Okazawa, Y.Fujibayashi
    The 7th Conference of Asian Society for Mitochondrial Research and Medicine and The 10th Conference of Japanese Society of Mitochondrial Research and Medicine Dec.  2010
  • Development of radiobromine-labeled thymidine analogue as a tumor proliferation imaging agent
    Y.Kiyono, K.Sano, T.Mori, M.E.Martinez, T.Asai, H.Okazawa, Y.Fujibayashi
     Sep.  2010
  • Development of flexible automatic liquid handling modules for PET probe preparation
    T.Mori, R.Watanabe, Y.Yoshii, Y.Kiyono, T.Asai, Y.Fujibayashi
     Sep.  2010
  • Evaluation of radiobromine-labeled 5-bromo-4’-thio-2’-deoxyuridine as a tumor proliferation imaging agent.
    Y.Kiyono, K.Sano, Y.Nakayama, T.Mori, J.Toyohara, M.E.Martinez Pozo, K.S.Mandap, T.Asai, H.Okazawa, Y.Fujibayashi
     Jun.  2010
  • Automated synthesis of 16β-[18F]fluoro-5α-dihydrotestosterone using a cassette-type FDG synthesizer
    T.Mori, Y.Kiyono, T.Asai, Y.Yoshii, H.Okazawa, C.S.Dence, M.J.Welch, Y.Fujibayashi
     Jun.  2010
  • Evaluation of 64Cu-ATSM for an internal radiotherapy agent: 64Cu-ATSM treatment reduces CD133+ highly tumorigenic cells and metastatic ability of tumors
    Yukie Yoshii, Takako Furukawa, Yasushi Kiyono, Ryo Watanabe, Tetsuya Mori, Hiroshi Yoshii, Hidehiko Okazawa, M. J. Welch, Yasuhisa Fujibayashi
    The Society of Nuclear Medicine (SNM) annual meeting 2010 Jun.  2010
  • Different distribution of 62Cu-ATSM and 18F-FDG in head-and-neck cancers
    H.Okazawa, M.Oh, T.Kudo, Y.Kiyono, M.Kobayashi, T.Mori, Y.Fujibayashi
     Jun.  2010
  • Metabolite analysis of Cu-64 labeled core-shell PEGylated star-like copolymer as a platform for drug delivery nanosystem
    T. Mori, A. Hagooly, E. Pressly, K. Fukukawa, C. Hawker, M. J. Welch
    Japanese Society for Molecular Imaging May  2010
  • Development of norepinephrine transporter imaging probe
    Y.Kiyono, N.Kanegawa, T.Sugita, K.S.Mandap, T.Mori, H.Saji, H.Okazawa, Y.Fujibayashi
    International Conference on Brain Function and Development Jan.  2010
  • Development of microwave-based autmated nucleophilic[18 F]fluorination system and its application for the production of[18F]flumazenil
    K.S.Mandap, T.Ido, Y.Kiyono, M.Kobayashi, T.G.Lohith, T.Mori, S.Kasamatsu, T.Kudo, H.Okazawa, Y.Fujibayashi
    Internatioal Conference on Brain Function and Development Jan.  2010
  • Automatic labeling method for injectabel 15O-oxygen using hemoglobin-containing liposome vesicles and its application for measurement of brain oxygen consumption by PET
    V.N.Tiwari, Y.Kiyono, M.Kobayashi, T.Mori, T.Kudo, H.Okazawa, Y.Fujibayashi
    International Conference on Brain Function and Development Jan.  2010
  • Development of radiobromine-labeled 5-bromo-4’-thio-2’-deoxyuridine as a tumor proliferation imaging agent.
    Y.Kiyono, K.Sano, Y.Nakayam, T.Mori, J.Toyohara, M.E.Martinez, K.S.Mandap, T.Asai, H.Okazawa, Y.Fujibayashi
     Jan.  2010
  • Feasibility of 62Cu-ATSM PET to delineate misery perfusion in patients with major cerebral arterial occlusive disease.
    H.Okazawa, M.Isozaki, Y.Arai, Y.Kiyono, T.Kudo, T.Mori, K.Kikuta
     Jan.  2010
  • 64Cu-ATSM imaging for cancer stem cell-rich regions: in vivo and in vitro characterization
    Y.Yoshii, Y.Kiyono, A.Waki, R.Watanabe, Y.Suzuki, T.Mori, H.Yoshii, T.Furukawa, T.Asai, T.Kudo, H.Okazawa, M.J.Welch, Y.Fujibayashi
     Sep.  2009
  • Automatic synthesis of 16beta-[18F]fluoro-5alpha-dihydrotestosterone using cassette-type [18F]FDG synthesizer
    Y.Kiyono, T.Mori, T.Asai, Y.Yoshii, H.Okazawa, Carmen S.Dence, Michael J.Welch, Y.Fujibayashi
     Sep.  2009
  • Long-term evaluation of a commercially available 68Ge/68Ga generator for PET imaging
    T.Mori, A.Hagooly, C.Glaus, R.Rossin, M.J.Welch
     Jul.  2009
  • Hypoxia imaging agent 64Cu-ATSM visualizes cancer stem cell-rich regions within tumors
    Y.Yoshii, Y.Kiyono, R.Watanabe, A.Waki, T.Mori, Y.Yoshii, T.Furukawa, M.Oh, M.Kobayashi, M.Welch, Y.Fujibayashi
    Society of Nuclear Medicine, the 56th Annual Meeting Jun.  2009
  • Analysis of metabolites of Cu-64 labeled DOTA PEGylated star-like copolymeric nanoparticles
    T.Mori, Aviv.Hagooly, Eric.Pressly, K.Fukukawa, Craig.Hawker, Michael.J.Welch
     Jun.  2009
  • Hypoxic metabolism as a target for tumor imaging
    Y.Fujibayashi, Y.Yoshii, T.Furukawa, T.Mori, Y.Kiyono
     May  2009
  • Injectable O-15 system for oxygen metabolism studies using Hemoblobin vesicle (HbV):automatic labeling and applivation in rats using PET
    V.N.Tiwari, H.Okazawa, M.Kobayashi, T.Mori, S.Kasamatsu, Y.Fujibayashi
     Dec.  2008
  • Preparation and biological evalution of [18F]Flumazenil synthesized utilizing a mondified microwave reactor system
    K.S.Mandap, T.Ido, Y.Kiyono, M.Kobayashi, T.G.Lohith, T.Mori, S.Kasamatsu, H.Okazawa, Y.Fujibayashi
     Dec.  2008
  • Hypoxic metabolism as a target for tumor imaging/therapy
    Y.Fujibayashi, Y.Yoshii, T.Furukawa, T.Mori, Y.Kiyono
    The 36th Annual Conference International Society on Oxygen Transport to Tissue Aug.  2008
  • Effect of L-systeine on bimding efficiency of hemoglobin-vesicles for development of an injectable O-15 labeling system.
    V.N.Tiwari, S.Kasamatsu, T.Mori, M.Kobayashi, H.Okazawa, Y.Fujibayashi
    The 55th SNM Annual Meeting Jun.  2008
  • Tumor acetate imaging: a new paradigm for understanding tumor-specific hypoxic metabolism
    Y.Yoshii, T.Furukawa, H.Yoshii, T.Mori, M.Kobayashi, Y.Kiyono, Y.Fujibayashi
     Jun.  2008
  • Preparation and biological evaluation of [18F]Flumazenil synthesized utilizing a modified microwave reactor system
    K.S.Mandap, T.Ido, S.Kasamatsu, T.Mori, Y.Kiyono, T.G.Lohith, M.Kobayashi, Y.Fujibayashi
     Jun.  2008
  • Preparation and biological evaluation of [18F]Flumazenil synthesized utilizing a modified microwave reactor system
    K.S.Mandap, 清野 泰, 小林 正和, T.G.Lohith, 森 哲也, 笠松 眞吾, 井戸 達雄, 藤林 康久
     May  2008
  • Radioiodinated (2S,αS)-2-[α-(2-iodophenoxy)benzyl]morpholine as a PET tracer for neuroendocrine tumor imaging
    Y.Kiyono, R.Nishii, J.Balatoni, T.Mori, J.G.Gelovani, Y.Fujibayashi
     Sep.  2007
  • A noble O-15 automatic labeling system using hemoglobin vesicle for clinical oxygen metabolism studies
    V.N.Tiwari, S.Kasamatsu, H.Haddad, T.Mori, M.Kobayashi, Y.Fujibayashi
     Jun.  2007
  • Tumor-specific fermentative pathway for energy production: a possible target for tumor imaging
    Y.Yoshii, T.Furukawa, H.Yoshii, T.Mori, Y.Fujibayashi
     Jun.  2007
  • Evaluation of a new PET tracer-reporter gene system for monitoring gene therapy
    Talakad Goolaiah Lohith, T.Furukawa, S.Takamatsu, T.Mori, Y.Fujibayashi
     Dec.  2006
  • Injectable 15O system for clinical oxygen metabolism studies using Hemoglobin-vesicles
    Tiwari Vijay Narayan, S.Kasamatsu, T.Mori, M.Kobayashi, Y.Fujibayashi
     Dec.  2006
  • Evaluation of New Adenoviral Mediated In Vivo FES-Herl PET Tracer-Reporter Gene System for Gene Therapy Monitoring
    Talakad Goolaiah Lohith, T.Furukawa, S.Takamatsu, T.Mori, Y.Fujibayashi
     Aug.  2006
  • Injectable 15O system for clinical oxygen metabolism studies using hemoglobin vesicles(HbV)as artificial oxygen carrier
    V.N.Tiwari, S.Kasamatsu, T.Mori, M.Kobayashi, Y.Fujibayashi, Y.Yonekura
    Society of Nuclear Medicine, The 53rd Annual Meeting Jun.  2006
  • Development of a low cost multipurpose system for F-18 labeled PET probe synthesis
    T.Mori, M.Kunieda, H.Okazawa, Y.Kiyono
    The 62nd Annual Meeting of The Society of Nuclear Medicine Jun.  2015 Society of Nuclear Medicine and Molecular Imaging(SNMMI)
  • Estimation of noninvasive arterial input in brain O-15 water PET study
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H
    The 56th Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Nov.  2016 The Japanese Society of Nuclear Medicine
  • Evaluation of radiobromine-labeled (2S,αS)-2-(α-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain norepinephrine transporter.Evaluation of radiobromine-labeled (2S,αS)-2-(α-(2-bromophenoxy)benzyl)morpholine as an imaging probe for brain norepinephrine transporter.
    Y.Kiyono, T.Mori, T.Asai, Y.Fujibayashi, H.Okazawa
     Jun.  2012
  • ノルエピネフリン・トランスポータイメージングプローブを用いた腫瘍イメージング
    清野 泰, 西井 龍一, 森 哲也, 小林 正和, 吉井 幸恵, 岡沢 秀彦, Gelovani Juri, 藤林 康久
     Nov.  2007
  • An injectabel O-15 automatic labeling system using hemoglobin vesicle(HbV)
    V.N.Tiwari, T.Mori, M.Kobayashi, Y.Fujibayashi
     Sep.  2007
  • In vivo evaluation of adenoviral mediated FES-hERL PET tracer-reporter gene system for gene therapy monitoring
    T.G.Lohith, T.Furukawa, T.Mori, M.Kobayashi, Y.Fujibayashi
     Sep.  2007
  • Evaluation of quantitative accuracy using the transmissionless-based emission segmented attenuation correction method in small animal PET
    M.Kobayashi, H.Okazawa, M.Oh, T.Tsujikawa, T.Mori, K.Sakai, M.Watanabe, Y.Kiyono, T.Kudo, K.Kawai, Y.Fujibayashi
     Sep.  2007
  • Differential diagnosis of endometrial hyperplasia and cancer using combined 18F-FES and 18F-FDG PET
    T.Tsujikawa, H.Okazawa, Y.Yoshida, T.Mori, K.Kobayashi, T.Tsuchida, Y.Fujibayashi
    The 54th Annual Meeting of the Society of Nuclear Medicine Jun.  2007
  • Tumor-specific fermentative pathway for nergy production : A possible target for tumor imaging.
    Y.Yoshii, T.Furukawa, H.Yoshii, T.Mori, Y.Fujibayashi
     Jun.  2007
  • Development of [18F]ethyl fluoroacetate as a tracer of oxidative metabolism in the brain
    T.Mori, L.Sun, M.Kobayashi, Y.Kiyono, T.Furukawa, H.Okazawa, Y.Fujibayashi
     Jun.  2007
  • Nucleophilic 18F-radiofluorination by a modified microwave reactor system
    K.S.Mandap, T.Ido, D.Hirayama, T.Mori, T.Asai, Y.Fujibayashi
     May  2007
  • Development of a simple automatic preparation system using solid phase extraction method for 16α-(18F)fluoro-17β-estradiol((18F)FES
    T.Mori, S.Kasamatsu, T.Ido, Y.Fujibayashi
     May  2007
  • Design and application of a general-purpose automatic liquid handling module for PET tracers
    T.Mori, D.Hirayama, T.Ido, S.Kasamatsu, T.Asai, Y.Fujibayashi
     May  2007
  • Feasibility of F-18 FES-PET for gynecological tumors
    T.Tsujikawa, H.Okazawa, Y.Yoshida, T.Mori, T.Tsuchida, T.Kurokawa, M.Kobayashi, Y.Fujibayashi
     Sep.  2006
  • Evaluation of gynecological tumors and endometriosis using [F-18]-fluoroestradiol and PET
    H.Okazawa, Y.Yoshida, T.Mori, T.Tsuchida, T.Kurokawa, M.Kobayashi, T.Tsujikawa, Y.Yonekura, Y.Fujibayashi
    Annual Congress of the European Association of Nuclear Medicine Sep.  2006
  • How accurately can reductions in baseline CBF and vasoreactivity detect misery perfusion in cerebrovascular disease?
    H.Okazawa, T.Tsuchida, Y.Arai, M.Kobayashi, T.Mori, T.Tsujikawa, Y.Yonekura, Y.Fujibayashi
    Annual Congress of the European Association of Nuclear Medicine Sep.  2006
  • Diagnosis of misery perfusion using noninvasive 15O-gas PET
    M.Kobayashi, H.Okazawa, T.Tsuchida, K.Kawai, T.Mori, T.Tsujikawa, Y.Yonekura, Y.Fujibayashi
    Annual Congress of the European Association of Nuclear Medicine Sep.  2006
  • Development of [18F]Ethyl fluoroacetate as a tracer of acetate metabolism imaging in whole body
    T.Mori, M.Kobayashi, L.Q.Sun, H.Kawashima, Y.Kiyono, Y.Fujibayashi
     Sep.  2006
  • Evidence of tumor-specific acetate production: basic study to find a possible biomarker for tumor imaging
    Y.Yoshii, T.Furukawa, H.Yoshii, T.Mori, Y.Fujibayashi
     Aug.  2006
  • Evaluation of uterine endometrium related gynecological diseases using F-18 fluoroestradiol and PET
    H.Okazawa, Y.Yoshida, T.Mori, T.Tsuchida, T.Kurokawa, M.Kobayashi, Y.Fujibayashi, Y.Yonekura
     Jun.  2006
  • Evaluation of gynecological tumors and endometriosis using F-18 fluoroestradiol and PET
    H.Okazawa, Y.Yoshida, T.Tsujikawa, T.Mori, T.Tsuchida, M.Kobayashi, Y.Fujibayashi
    The 9th Congress of World Federation of Nuclear Medicine & Biology Jan.  2006
  • Synthesis and evaluation of [F-18]Ethyl fluoroacetate as a tracer of imaging oxidative metabolism in whole body
    T.Mori, L.Q.Sun, M.Kobayashi, H.Kawashima, Y.Fujibayashi
     Jan.  2006
  • Evaluation of ethyl[18F]fluoroacetate as atracer of acetic acid metabolism in brain
    T.Mori, L.Q.Sun, M.Kobayashi, H.Kawashima, M.J.Welch, Y.Yonekura, Y.Fujibayashi
     Dec.  2005
  • Development of adenoviral mediated [18F]-FES-hERL In Vivo PET tracer-reporter gene system for monitoring of gene therapy
    Lohith, T. G., Furukawa, T., Takamatsu, S., Mori, T., Fujibayashi, Y.
     Dec.  2005
  • Evaluation of [18F]FES-hERL repoter gene system in vivo for gene therapy
    Furukawa, T., Lohith, T. G., Takamatsu, S., Mori, T., Tanaka, T., Fujibayashi, Y.
     Sep.  2005
  • Development of adenoviral medicated [16F]-FES-hERL In Vivo PET tracer-repoter gene system for monitoring of gene therapy
    Lohith, T. G., Furukawa, T., Takamatsu, S., Mori, T., Tanaka, T., Fujibayashi, Y.
     Sep.  2005
  • Automated radiosynthesis of a novel [18F]fluoroethylation agent
    L.Q.Sun, T.Furukawa, T.Mori, S.Kasamatsu, Y.Yonekura, Y.Fujibayashi
     Jul.  2005
  • Evaluation of critical hemodynamic status induced by acetazolamide challenge in patients with cerebrovascular disease:assessment of regional perfusion pressure.
    H.Okazawa, T.Tsuchida, Y.Arai, T.Mori, M.Kobayashi, F.Tanaka, Y.Yonekura
    Brain '05 & BrainPET '05 Jun.  2005
  • Fluorine-18 fluoroestradional uptake in endometirum-influence of menstrual cycle and endogenous estrogen level.
    T.Tsuchida, H.Okazawa, Y.Fujibayashi, T.Mori, F.Tanaka, M.Kobayashi, K.Sugimoto, Y.Yonekura, H.Itoh
    Society of Nuclear Medicine 52nd Annual Meeting Jun.  2005
  • Effects of 5-HT1B/1D receptor agonist on cerebral blood flow and arterial blood volume:PET study with healthy volunteers.
    H.Okazawa, T.Tsuchida, M.Pagani, T.Mori, F.Tanaka, M.Kobayashi, Y.Yonekura
    Human Brain Mapping 2005 Jun.  2005
  • Fully automated synthesis of sodium [18F]fluoroacetate
    L.Q.Sun, T.Mori, Y.Yonekura, Y.Fujibayashi
     Jun.  2005
  • Relationship between misery perfusion and vasodilatory capacity assessed by acetazolamide test in patients with cerebrovascular disease:a PET syudy with O-15 gas and water
    H.Okazawa, T.Tsuchida, Y.Arai, T.Mori, M.Kobayashi, F.Tanaka, Y.Fujibayashi, Y.Yonekura
     Jun.  2005
  • Automatic synthesis of 16α-[18F]fluoro-17β-estradiol using a cassette type FDG synthesizer
    Mori, T., Kasamatsu, S., Mosdzianowski, C., Welch, M. J., Fujibayashi, Y.
     Jun.  2005
  • New aproach to the preparation of Ethyl [18F]fluoroacetate-a simple method via distillation
    L.Q.Sun, T.Mori, T.Furukawa, Y.Yonekura, Y.Fujibayashi
     Jun.  2005
  • Purification of O-18 water with a crystal water method
    L.Q.Sun, T.Mori, S.Kasamatsu, Y.Fujibayashi
     Jan.  2005
  • Localization of partial epilepsy using simultaneous recording of EEG and fMRI
    F.Tanaka, K.Anami, T.Mori, T.Ohnishi, H.Matsuda, O.Saitoh, Y.Yonekura
     Dec.  2004
  • Preliminary study on ethyl-ester of [18F]fluoroacetic acid as a tracer of acetic acid metabolism in brain
    T.Mori, L.Q.Sun, Y.Fujibayashi
     Dec.  2004
  • Evaluation of [18F]FES-hERL in vivo reporter gene system for gene therapy monitoring
    T.Furukawa, T.G.Lohith, S.Takamatsu, T.Mori, T.Tanaka, Y.Fujibayashi
     Dec.  2004
  • Development of adenoviral-mediated PET tracer-reporter gene system for monitoring of gene therapy
    T.G.Lohith, T.Furukawa, S.Takamatsu, T.Mori, Y.Fujibayashi
     Dec.  2004
  • Non-invasive imaging of transplanted living functional cells transfected with a reporter estrogen receptor gene
    S.Takamatsu, T.Furukawa, T.Mori, Y.Yonekura, Y.Fujibayashi
     Dec.  2004
  • Preparation of 16α-[18F]fluoro-17β-estradiol using a cassette type FDG synthesizer
    Mori, T., Kasamatsu, S., Fujibayashi, Y.
     Dec.  2004
  • Development of preparation of [18F]fluoroacetate with a commercial auto-synthesizer
    L.Q.Sun, T.Mori, S.Kasamatsu, Y.Fujibayashi
     Dec.  2004
  • Evaluation of critical changes in cerebral perfusion pressure induced by vasodilatory stimulus in patients with cerebrovascular disease
    H.Okazawa, T.Tsuchida, T.Mori, Fujibayashi, Y., Y.Yonekura
     Dec.  2004
  • Radio-labeled probes for molecular-genetic imaging
    Y.Fujibayashi, T.Furukawa, S.Takamatsu, T.Mori, Y.Yonekura
     Nov.  2004
  • Evaluation of BOLD changes related to interictal epileptic discharges using continuous and simultaneous EEG-fMRI
    F.Tanaka, K.Anami, T.Mori, T.Ohnishi, Y.Yonekura, H.Matsuda, O.Saitoh
     Jun.  2004
  • Non-invasive imaging of transplanted living functional cells transfected with a reporter estrogen receptor gene
    S.Takamatsu, T.Furukawa, T.Mori, Y.Yonekura, Y.Fujibayashi
     Jun.  2004
  • PET tracer-reporter gene system for monitoring of gene therapy
    T.G.Lohith, 古川 高子, 高松 真二, 森 哲也, 藤林 康久
     Nov.  2003
  • Assessment of hormone sensitivity in uterine leiomyoma patients using 18F-FES PET
    T.Tsujikawa, Y.Chino, A.Shinagawa, M.Yamamoto, A.Makino, T.Mori, T.Kurokawa, Y.Kiyono, Y.Yoshida, H.Okazawa
    SNMMI 2015 Annual Meeting
  • Evaluation of a new precursor for radiosynthesis of 2-deoxy-2-[18F]fluoroacetamido-D-glucopyranose
    ME. Martinez, Y.Tokunaga, T.Mori, A.Makino, H.Okazawa, Y.Kiyono
    10th Annual Meeting of Japanese Society for Molecular Imaging May  2015
  • Evaluation of nigrostriatal oxidative stress intensity in patients with Parkinson’s disease using [Cu-62]ATSM PET and FP-CIT SPECT.
    H.Okazawa, M.Ikawa, T.Tsujikawa , T.Mori, A.Makino, Y.Kiyono, M.Yoneda
    Annual Congress of the European Association of Nuclear Medicine (EANM2015)  Oct.  2015
  • Evaluation of Striatal oxidative stress in Parkinson’s disease using [Cu-62]ATSM PET.
    H.Okazawa, M.Ikawa, T.Tsujikawa, T.Mori, Y.Kiyono, M.Yoneda
    Brain & Brain PET 2015 (XXVIIth International Symposium on Cerebral Blood Flow, Metabolism and Function) Jun.  2015
  • Prediction of head and neck cancer outcome evaluated by tumor redox status using 62Cu-ATSM PET.
    T.Tsujikawa, S.Asahi, M.Oh, T.Mori, Y.Kiyono, H.Okazawa
    The 62th Annual Meeting of The Society of Nuclear Medicine Jun.  2015
  • Predictive value of early stage uptake of 3'-deoxy-3'-18F-fluorothymidine in colorectal cancer treated with charged particle irradiation.
    Y.Kiyono, C.Lin, K.Kume, T.Mori, ME.Martinez, H.Okazawa
    62nd Annual Meeting of Society of Nuclear Medicine Jun.  2015
  • Hypoxic intensity and tumor burden measured by 62Cu-ATSM-PET in head and neck cancer patients: Comparison of prognostic prediction with FDG-PET
    T.Tsujikawa, S.Asahi, M.Oh, Y.Sato, T.Mori, Y.Kiyono, S.Fujieda, H.Kimura, H.Okazawa
    第74回日本医学放射線学会学術集会 Apr.  2015
  • Development of a low cost multipurpose synthesis system for F-18 PET tracers
    T.Mori, M.Kunieda, Y.Fujibayashi, H.Okazawa, Y.Kiyono:
    Ninth Japan-China Joint Seminar on Radiopharmaceutical Chemistry (JCSRC2015). Nov.  2015
  • PET Imaging of Estrogen Receptors in Metastatic Breast Cancer
    Maeda H, Higashi M, Tsuchida T, Mori T,Tsujikawa T, Imamura Y, Okazawa H, Goi T
     Oct.  2016
  • Clinical benefits of precise delay correction for CBF measurement in O-15 water PET study.
    Islam MM, Tsujikawa T, Mori T, Kiyono Y, Okazawa H.
    The 63th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging Jun.  2016 Society of Nuclear Medicine
  • Predictive value of 3'-deoxy-3'-18F-fluorothymidine uptake in colorectal cancer treated with carbon ion irradiation under hypoxic condition.
    Kiyono Y, Kume K, Mori T, Okazawa H
    The 63th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging Jun.  2016
  • Functional images predict prognosis of uterine sarcoma patient: Estrogen receptor expression combined with FDG PET
    Tsujikawa T, Yamamoto M, Chino Y, Shinagawa A, Tsuchida T, Mori T, Kurokawa T, Kiyono Y, Yoshida Y, Okazawa H
    The 63th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging Jun.  2016 Society of Nuclear Medicine
  • Predictive value of 3'-deoxy-3'-18F-fluorothymidine uptake in colorectal cancer treated with proton irradiation under hypoxic condition.
    Kiyono Y, Murata M, Makino A, Kume K, Mori T, Asai T, Okazawa H
    The 64th Annual Meeting of The Society of Nuclear Medicine Jun.  2017
  • Prognostic value of FES PET in patients with endometrial cancer
    Tsujikawa T, Yamada S, Tsuyoshi H, Kurokawa T, Shinagawa A, Chino Y, Mori T, Makino A, Kiyono Y, Yoshida Y
     May  2017
  • 18F-FES and 18F-FDG PET/MR imaging of gynecologic tumors:Initial experience in 5 cases
    Tsujikawa T, Tsuyoshi H, Yamada S, Shinagawa A, Chino Y, Mori T, Kurokawa T, Kiyono Y, Yoshio Y, Okazawa H
    The 64th Annual Meeting of The Society of Nuclear Medicine Jun.  2017
  • Automated Synthesis of[18F]FFNP and[18F]FES with a low cost module systems
    Mori T, Kunieda M, Asai T, Okazawa H, Kiyono Y
    22nd International Symposium on Radiopharmaceutical Sciences(ISRS2017) May  2017
  • Measurement of cerebral blood flow with H215O PET/MRI.
    Okazawa H, Tsujikawa T, Higashino Y, Arishima H, Mori T, Kiyono Y, Kikuta K.
    Brain & Brain PET 2017 Apr.  2017
  • Measurement of cerebral blood flow using H215O PET/MRI with a noninvasive method.
    Okazawa H, Higashino Y, Tsujikawa T, Mori T, Arishima H, Kiyono Y, Kikuta K.
    The 64th Annual Meeting of The Society of Nuclear Medicine Jun.  2017
  • Assessment of bone marrow proliferation in bone marrow failure syndrome by FLT-PET/MRI
     Nov.  2018
  • Development of nanoparticles for internal radiation therapy
     Nov.  2018
  • Examination on simple preparation method of Cu-64 labeled nanoparticle
     May  2018
  • Predictive value of 18F-FDG and 18F-FLT uptake in colorectal cancer treated with charged particle irradiation under hypoxic condition
    Kiyono Y, Makino A,Kume K,Mori T,Asai T, Okazawa H
    The 65th Annual Meeting of The Society of Nuclear Medicine Jun.  2018
  • Changes in the accumulation of 18F-FDG and 18F-FLT in colorectal cancer cells treated with charged particle irradiation under hypoxic condition
    Kiyono Y, Kume K, Makino A, Mori T, Asai T, Okazawa H
    The 12th World Congress of the World Federation of Nuclear Medicine and Biology (WFNMB 2018) Apr.  2018
  • Validation study of F-18 labeled sodium fluoride (NaF) for a GMP production
     Nov.  2018
  • Validation of a bacterial decontaminant by vaporized hydrogen peroxide in PET drug area
     Nov.  2018